CX Institutional’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-6,797	Closed	-$591K	–	669
2021 Q3	$591K	Buy	6,797 +1,065	+19%	+$92.6K	0.05%	244
2021 Q2	$469K	Buy	+5,732	New	+$469K	0.04%	253
2019 Q3	–	Sell	-26	Closed	-$2K	–	887
2019 Q2	$2K	Buy	+26	New	+$2K	﹤0.01%	766